Genetic dysfunction of <i>MT-ATP6</i> causes axonal Charcot-Marie-Tooth disease
Robert D. S. Pitceathly(National Hospital for Neurology and Neurosurgery), Michael G. Hanna(International Research Associates (United States)), Michael R. Rose(University of Oxford), Carol A. Crowe(Cleveland Clinic), Ellen Cottenie(UCL Australia), Mary M. Reilly(University College London), Cheryl Longman, Ese Mudanohwo(University College London), Rupert Page(Poole Hospital NHS Foundation Trust), Shamima Rahman(Great Ormond Street Hospital for Children NHS Foundation Trust), Janice L. Holton(National Hospital for Neurology and Neurosurgery), Sinéad M. Murphy(Trinity College Dublin), Michael P. Lunn(UCL Australia), Frances Flinter(Guy's and St Thomas' NHS Foundation Trust), Henry Houlden(National Hospital for Neurology and Neurosurgery), Annapurna Chalasani(UCL Australia), Michael Champion, Jacqueline Palace(Mayo Clinic), Iain P. Hargreaves(Liverpool John Moores University), John M. Land(UCL Australia), Cathy E. Woodward(University College London), Simon Heales(UCL Australia), Mary G. Sweeney(University College London), Julian Blake(Norfolk and Norwich University Hospitals NHS Foundation Trust), S. Robb(University College London)
Cited by 111
Related Papers
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases
|Nature|1993|1.5k
New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey
|Journal of Medical Genetics|1999|971
X-linked Alport Syndrome
|Journal of the American Society of Nephrology|2000|592
Serologic diagnosis of NMO
|Neurology|2012|526